StockNews.com assumed coverage on shares of Arcadia Biosciences (NASDAQ:RKDA – Free Report) in a research note released on Saturday morning. The brokerage issued a sell rating on the basic materials company’s stock.
Arcadia Biosciences Price Performance
Shares of RKDA opened at $5.01 on Friday. Arcadia Biosciences has a 12 month low of $1.85 and a 12 month high of $10.31. The stock has a fifty day moving average price of $4.81 and a 200 day moving average price of $3.70. The company has a market cap of $6.84 million, a P/E ratio of -1.17 and a beta of 0.90.
Arcadia Biosciences Company Profile
Recommended Stories
- Five stocks we like better than Arcadia Biosciences
- Overbought Stocks Explained: Should You Trade Them?
- 3 Stocks to Gain From Donald Trump’s External Revenue Service
- Consumer Staples Stocks, Explained
- AMD: Loop Capital’s Buy Rating Reinforces Investor Confidence
- Bank Stocks – Best Bank Stocks to Invest In
- Momentum Is Building for Qualcomm to Have a Strong Run in 2025
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.